Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

Huge Bilateral Breast Hamartoma Accompanied with Pseudoangiomatous Stromal Hyperplasia

Baik H, Kim JW, Park YM, Jung SJ, Lee A, Yoon HK, Kim TH

A 34-year-old woman presented with sudden breast enlargement that had occurred within 6 months. She also had an accessory breast mass on the left axilla. Clinical impression was phyllodes tumor....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Results of Occult Breast Carcinoma Treated with Axillary Node Dissection Only: Five Cases Reports

Kim Y, Kim H, Cho J, Kwon S, Yeo S, Kang SH

Herein, we report five cases of occult breast cancer treated with axillary node dissection only, without breast surgery or whole breast radio-therapy. The patients complained of a large, hard mass...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictors for the Transition from Ductal Carcinoma In Situ to Invasive Breast Cancer in Korean Patients

Kim EY, Hyun KH, Park YL, Park CH, Do SI

PURPOSE: To identify predictive factors of upstaging from diagnosed ductal carcinoma in situ (DCIS) to invasive cancer after surgical excision. METHODS: One hundred seventy-four patients diagnosed with DCIS based on biopsies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinicopathologic Features of Pleomorphic Invasive Lobular Carcinoma: Comparison with Classic Invasive Lobular Carcinoma

Yeom C, Kim H, Kwon S, Kang SH

PURPOSE: The purpose of this study was to identify the clinical and pathological factors that differentiate pleomorphic invasive lobular carcinoma (PILC) from classic invasive lobular carcinoma (CILC). METHODS: We retrospectively reviewed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Implications of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome in the Era of Genomic Medicine: Clinician's Perspectives

Park HS, Park JS, Nam EJ, Lee ST, Han JW, Kim TI

Hereditary breast and ovarian cancer syndrome accounts for approximately 5% to 10% of breast or ovarian cancers, with which the high-penetrant BRCA1/2 genes have been associated. With the recent development...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr